Qilu Pharmaceutical & FDSTC Announce Strategic Partnership to Boost China’s Biomedical Innovation
China‑based Qilu Pharmaceutical and the Foundation for the Development of Science and Technology in China (FDSTC),...
Finance
ChemPartner & Toposcend Form $200 M Healthcare Fund to Back Innovative Drugs
ChemPartner Pharmatech Co., Ltd. (SHE: 300149) announced that its wholly‑owned subsidiary, Beihai ChemPartner Venture Capital...
IVD Medical Acquires 20 % of GoFintech in HK$3.14 B Deal
IVD Medical Holding Limited (HKG: 1931) disclosed that it will purchase 1,848,496,429 shares of GoFintech...
Minova Rongzhi Funding Surge: Series B Backed by IDG Capital
Nanjing‑based Minova Pharmaceuticals Co., Ltd. closed a Series B financing round worth hundreds of millions of...
InxMed Secures HK$100 M Private Placement from TruMed Health
On August 26, 2025, Hong Kong‑listed China-based InxMed (Nanjing) Co., Ltd (HKG: 2509) announced that it has...
Vibrant Therapeutics Secures Multi-Million Series A Funding to Advance Intelligent Macromolecule Drugs
Vibrant Therapeutics, an innovative biotech company specializing in next-generation intelligent macromolecule drugs, announced on August...
Tianjin Lisheng Plans RMB 1 Billion Fund with Strategic Partners
Tianjin Lisheng Pharmaceutical Co., Ltd. (SHE: 002393), based in China, announced plans to co-establish the...
Haohai Biotech Terminates OK Lens Distribution Deal with Brighten Optix Amid Carl Zeiss Acquisition
Shanghai Haohai Biological Technology Co., Ltd. (HKG: 6826, SHA: 688366) announced the termination of its...
Vivatides Therapeutics Completes Multi-Million Dollar Seed Financing to Advance Nucleic Acid Delivery Platform
Biopharmaceutical company Vivatides Therapeutics has successfully completed a multi-million dollar seed round financing led by...
Sino Biopharmaceutical on Track to Receive $300M Milestone Payment for PD-1/VEGF Antibody Deal
China-based Sino Biopharmaceutical Ltd (HKG: 1177) has announced that the out-licensing collaboration between its subsidiary...
Shanghai Biomedicine M&A Fund Acquires Stake in MicroPort via Share Transfer Agreement
The Shanghai Biomedicine Merger and Acquisition Fund under SIIC Capital has entered into a share...
Tibet Aim Pharm’s Major Shareholder Transfers Stake to Beijing Fuhao
China-based Tibet Aim Pharm, Inc. (SHE: 002826) announced that its controlling shareholder and actual controller,...
Velavigo Closes $60 Million Pre-A+ Financing Round to Advance Global Clinical Trials
Velavigo, a Shanghai-based pharmaceutical startup, has reportedly secured USD 60 million in a Pre-A+ financing...
Everest Medicines Completes HK$1.57 Billion Share Placement to Advance R&D and Commercialization
China-based Everest Medicines (HKG: 1952) announced today the completion of a share placement of 22,561,000...
Shanghai Wankexin Biotech to Acquire Stake in Chengdu Kanghua Biological for RMB 1.851 Billion
Shanghai Wankexin Biotechnology Partnership Enterprise (Limited Partnership) (“Wankexin Biotech”), a subsidiary of the Shanghai Biomedicine...
VivaVision Biotech Closes D2+ Funding Round, Advancing Ophthalmic Therapies
VivaVision Biotech recently announced the successful closing of its D2+ funding round, raising 140 million...
Tcelltech Secures USD 40 Million Series B Funding for TX-103 CAR-T Therapy Development
China-based Tcelltech Ltd., a developer of T-cell immunotherapies, has reportedly secured close to USD 40...
Sino Biopharmaceutical Acquires Majority Stake in LaNova Medicines for USD 950.92 Million
China-based Sino Biopharmaceutical Ltd (HKG: 1177) announced the acquisition of a 95.09% stake in Shanghai-based...
ShuWen Biotech Completes RMB100 Million Series C1 Round to Advance Women’s Health Diagnostics
Zhejiang-based ShuWen Biotech Co., Ltd announced the successful completion of an RMB100 million (USD 14...
LakeShore Biopharma Secures $15 Million in Private Placement to Fuel Growth
China-based biopharmaceutical company LakeShore Biopharma Co., Ltd (NASDAQ: LSB) has announced the successful execution of...